BioMarin

BioMarin is a leading global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. To learn more, please visit www.BioMarin.com.